This page lists the SEC filings reported by Quaker BioVentures II LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-06-23 | Quaker BioVentures II LP | TELA Bio, Inc. | 18,096 | - | EDGAR |
| SC 13G/A | 2022-02-14 | Quaker BioVentures II LP | TELA Bio, Inc. | 1,769,196 | - | EDGAR |
| SC 13G/A | 2021-01-26 | Quaker BioVentures II LP | TELA Bio, Inc. | 1,769,196 | - | EDGAR |
| SC 13G | 2020-02-14 | Quaker BioVentures II LP | TELA Bio, Inc. | 1,769,196 | - | EDGAR |
| SC 13G/A | 2017-02-14 | Quaker BioVentures II LP | CEMPRA, INC. | 2,565,601 | - | EDGAR |
| SC 13G/A | 2016-02-12 | Quaker BioVentures II LP | INNOVUS PHARMACEUTICALS, INC. | 1,448,678 | - | EDGAR |
| SC 13G/A | 2015-02-13 | Quaker BioVentures II LP | INSMED Inc | 1,975,251 | - | EDGAR |
| SC 13G/A | 2015-02-13 | Quaker BioVentures II LP | TRANSENTERIX INC. | 2,516,570 | - | EDGAR |
| SC 13G/A | 2014-08-07 | Quaker BioVentures II LP | HORIZON PHARMA, INC. | - | - | EDGAR |
| SC 13D/A | 2014-02-24 | Quaker BioVentures II LP | NUPATHE INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2014-02-13 | Quaker BioVentures II LP | CEMPRA, INC. | 3,565,601 | - | EDGAR |
| SC 13G/A | 2014-02-13 | Quaker BioVentures II LP | Durata Therapeutics, Inc. | 1,533,333 | - | EDGAR |
| SC 13G | 2014-02-13 | Quaker BioVentures II LP | TRANSENTERIX INC. | 12,582,848 | - | EDGAR |
| SC 13G | 2014-01-09 | Quaker BioVentures II LP | INNOVUS PHARMACEUTICALS, INC. | 1,647,325 | - | EDGAR |
| SC 13G/A | 2013-02-14 | Quaker BioVentures II LP | HORIZON PHARMA, INC. | - | - | EDGAR |
| SC 13G/A | 2013-02-14 | Quaker BioVentures II LP | INSMED INC | 2,927,094 | - | EDGAR |
| SC 13D/A | 2012-10-25 | Quaker BioVentures II LP | NUPATHE INC. | 7,830,706 | 39.6% | EDGAR |
| SC 13D | 2012-10-05 | Quaker BioVentures II LP | NUPATHE INC. | 2,830,706 | 19.2% | EDGAR |
| SC 13G | 2012-07-27 | Quaker BioVentures II LP | Durata Therapeutics, Inc. | 1,333,333 | - | EDGAR |
| SC 13G | 2012-03-09 | Quaker BioVentures II LP | HORIZON PHARMA, INC. | - | - | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.